We predicted that EP300/CBP KD would increase disease promoting Aβ42 secretion, because (1) Aβ-reducing genes were downregulated in EP300/CBP KD, and (2) EP300/CBP regulated genes were enriched for genes upregulated in healthy aged human brains compared to AD brains. This evidence concerns the gene EP300 and Alzheimer disease.